← Open Payments lookup

REEMON BISHARA: Open Payments

NPI 1750308623 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$950 in 23 payments from 9 companies in 2025. Trend: 2023 $572 · 2024 $832 · 2025 $950

Food & beverage: $950
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$178
Axsome Therapeutics, Inc.3$178
Janssen Pharmaceuticals, Inc3$170
Neurocrine BioSciences, Inc.1$119
E.R. Squibb & Sons, L.L.C.3$107
Teva Pharmaceuticals USA, Inc.4$88
Otsuka Pharmaceutical Development & Commercialization, Inc.2$42
Alkermes, Inc.2$37
Vanda Pharmaceuticals Inc.1$31

Products named: Auvelity, INVEGA SUSTENNA, ABILIFY MAINTENA, INGREZZA, COBENFY, UZEDY, ABILIFY ASIMTUFII, ARISTADA.

Industry payments across NY — which companies pay providers there.